uric acid has been researched along with Nasopharyngeal Carcinoma in 3 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
Nasopharyngeal Carcinoma: A carcinoma that originates in the EPITHELIUM of the NASOPHARYNX and includes four subtypes: keratinizing squamous cell, non-keratinizing, basaloid squamous cell, and PAPILLARY ADENOCARCINOMA. It is most prevalent in Southeast Asian populations and is associated with EPSTEIN-BARR VIRUS INFECTIONS. Somatic mutations associated with this cancer have been identified in NPCR, BAP1, UBAP1, ERBB2, ERBB3, MLL2, PIK3CA, KRAS, NRAS, and ARID1A genes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To explore the combined predictive value of serum uric acid (SUA) and tumor response to induction chemotherapy (IC) in locally advanced nasopharyngeal carcinoma (LANPC) patients receiving IC followed by concurrent chemoradiation therapy (CCRT)." | 8.02 | Prognostic value of serum uric acid and tumor response to induction chemotherapy in locally advanced nasopharyngeal carcinoma. ( Bai, P; Chen, C; Chen, Q; Lin, Z; Wu, Z; Xiao, Y; Xu, Y; Ye, W; Zheng, W, 2021) |
| "The purpose of this study was to determine the predictive value of pretreatment serum uric acid (SUA) for metastasis in locally advanced nasopharyngeal carcinoma (NPC) treated with intensity-modulated radiotherapy." | 7.85 | Use of pretreatment serum uric acid level to predict metastasis in locally advanced nasopharyngeal carcinoma. ( Chen, L; Du, XJ; Guo, R; Li, WF; Lin, AH; Ma, J; Mao, YP; Sun, Y; Tang, LL, 2017) |
| "The combined predictive value of plasma uric acid and primary tumor volume in nasopharyngeal carcinoma (NPC) patients receiving intensity modulated radiation therapy (IMRT) has not yet been determined." | 7.79 | Plasma uric acid and tumor volume are highly predictive of outcome in nasopharyngeal carcinoma patients receiving intensity modulated radiotherapy. ( Ge, N; Hu, WH; Lin, H; Lin, HX; Sun, R; Wang, HZ, 2013) |
| "To explore the combined predictive value of serum uric acid (SUA) and tumor response to induction chemotherapy (IC) in locally advanced nasopharyngeal carcinoma (LANPC) patients receiving IC followed by concurrent chemoradiation therapy (CCRT)." | 4.02 | Prognostic value of serum uric acid and tumor response to induction chemotherapy in locally advanced nasopharyngeal carcinoma. ( Bai, P; Chen, C; Chen, Q; Lin, Z; Wu, Z; Xiao, Y; Xu, Y; Ye, W; Zheng, W, 2021) |
| "The purpose of this study was to determine the predictive value of pretreatment serum uric acid (SUA) for metastasis in locally advanced nasopharyngeal carcinoma (NPC) treated with intensity-modulated radiotherapy." | 3.85 | Use of pretreatment serum uric acid level to predict metastasis in locally advanced nasopharyngeal carcinoma. ( Chen, L; Du, XJ; Guo, R; Li, WF; Lin, AH; Ma, J; Mao, YP; Sun, Y; Tang, LL, 2017) |
| "The combined predictive value of plasma uric acid and primary tumor volume in nasopharyngeal carcinoma (NPC) patients receiving intensity modulated radiation therapy (IMRT) has not yet been determined." | 3.79 | Plasma uric acid and tumor volume are highly predictive of outcome in nasopharyngeal carcinoma patients receiving intensity modulated radiotherapy. ( Ge, N; Hu, WH; Lin, H; Lin, HX; Sun, R; Wang, HZ, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, Y | 1 |
| Wu, Z | 1 |
| Ye, W | 1 |
| Xiao, Y | 1 |
| Zheng, W | 1 |
| Chen, Q | 1 |
| Bai, P | 1 |
| Lin, Z | 1 |
| Chen, C | 1 |
| Lin, H | 1 |
| Lin, HX | 1 |
| Ge, N | 1 |
| Wang, HZ | 1 |
| Sun, R | 1 |
| Hu, WH | 1 |
| Du, XJ | 1 |
| Chen, L | 1 |
| Li, WF | 1 |
| Tang, LL | 1 |
| Mao, YP | 1 |
| Guo, R | 1 |
| Sun, Y | 1 |
| Lin, AH | 1 |
| Ma, J | 1 |
3 other studies available for uric acid and Nasopharyngeal Carcinoma
| Article | Year |
|---|---|
Prognostic value of serum uric acid and tumor response to induction chemotherapy in locally advanced nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Aged; Child; Female; Humans; Induction Chemotherapy; Male; Middle Aged; Nasophary | 2021 |
Plasma uric acid and tumor volume are highly predictive of outcome in nasopharyngeal carcinoma patients receiving intensity modulated radiotherapy.
Topics: Adolescent; Adult; Aged; Biomarkers, Tumor; Carcinoma; Disease-Free Survival; Female; Humans; Kaplan | 2013 |
Use of pretreatment serum uric acid level to predict metastasis in locally advanced nasopharyngeal carcinoma.
Topics: Adult; Aged; Biomarkers; Carcinoma; China; Cohort Studies; Disease-Free Survival; Female; Humans; Ka | 2017 |